Note: Ingredients listed on restricted chemical lists
EC/CAS
7632-00-0
Name of the chemical
Sodium nitrite
Concentration
N/A
EC/CAS
231-555-9
Name of the chemical
Sodium nitrite
Concentration
N/A
General Information
Revision date
2020-07-02
Product name
Sika MonoTop -910 S
supplier name
Sika Hellas ABEE
Emergency telephone
30 210 77 93 777
Icons in SDS
Company Information
company name
Sika Hellas ABEE
e-mail address of the competent person responsible for the Safety Data Sheet
EHS@gr.sika.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
CLP CLASSIFICATION
Skin irritation, Category 2 H315: Causes skin irritation. Serious eye damage, Category 1 H318: Causes serious eye damage. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3, Respiratory system
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H315 Causes skin irritation. H318 Causes serious eye damage. H335 May cause respiratory irritation.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children.
Prevention
P271 Use only outdoors or in a well-ventilated ar- ea. P280 Wear protective gloves/ eye protection/ face protection.
Response
P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove con- tact lenses, if present and easy to do. Con- tinue rinsing. Immediately call a POISON CENTER/ doctor.
Disposal
P501 Dispose of contents/container in accordance with local regulation.
Hazardous Ingredients
Cement (chromium reduced)
2.3 Other hazards
The content of soluble Chromium (VI) is not greater than 0,0002% in accordance with Annex XVII, Paragraph 47 of the EU Regulation 1907/2006. The product reacts highly alkaline with water. This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
